Global Clinical Trial Imaging Market has been Driven by Increasing Number of Contract Research Organization, Increasing Prevalence of Chronic Diseases in the forecast period of 2019 to 2026

Global Clinical Trial Imaging Market is projected to register a substantial CAGR of 6.7% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Clinical Trial Imaging Market Access Full Report at https://www.databridgemarketresearch.com/reports/global-clinical-trial-imaging-market

Drivers: Global Clinical Trial Imaging Market​​​​​​​

  • Rising R&D expenditure
  • Increasing number of contract research organization

Restraints:

  • High risk radiation causing diseases
  • High implementation cost of imaging system

Opportunity:

  • Strategic initiatives for business expansion

Challenge:

  • Strict regulatory policies

Market Trends:

Global clinical trial imaging market is segmented into five notable segments which are basis of product & services, modality, application, end user and distribution channel.

  • On the basis of product & services, the market is segmented into services and software. Services segment is expected to dominate because it provides accurate data and consulting to pharma and biotech companies about the particular clinical trial which is beneficial for the companies to launch new molecules.
  • On the basis of modality, the market is segmented computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, X-ray, ultrasound, optical coherence tomography and others. Computed tomography segment is expected to dominate due to the rising number of chronic diseases.
  • On the basis of application, the market is segmented oncology, neurology, endocrinology, cardiology, dermatology, hematology and others
  • On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic and government research institutes, medical device manufacturers and others
  • On the basis of distribution channel, the market is segmented into direct sales and tender sales

Major Players: Global Clinical Trial Imaging Market​​​​​​​

Some of the major players operating in this market are BioTelemetry, Inc, IXICO plc, Resonance Health, Bioclinica, ICON plc, Radiant Sage LLC, Lyscaut Medical Imaging Company, Quotient Sciences, worldcare Clinical, Navitas Life Sciences, Cardiovascular Imaging Technologies, Intrinsic Imaging, Image Core Lab, ERT Clinical, Perspectum Diagnostics, Anagram 4 clinical trials, Parexel International Corporation among others.